Orthopedics > OCOSH Classification > Bone Diseases > Orthopaedic Oncology > Connective and Soft Tissue Neoplasms > Bone Neoplasms > Osteosarcoma > Chemotherapy Plus Muramyl Tripeptide Improves Osteosarcoma Survival

Next >

Chemotherapy Plus Muramyl Tripeptide Improves Osteosarcoma Survival

Visit Resource Review It Rate It Bookmark It

Location: http://www.medscape.com/viewarticle/570128

Description: The addition of muramyl tripeptide (MTP) to conventional chemotherapy for the treatment of osteosarcoma reduces mortality by about 30%, according to findings from long-term follow-up of a phase III trial.
Medscape summary of Meyers et al J Clin Oncol 2008;26:633-638.

Type: Reference Material
Author/Contact: Gale
Institution: Medscape
Primary Subject/Category:

Language: English

Submitted by: admin
Hits: 21
Added: Sun Mar 30 2008